Citation: Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM (2013) Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis. PLoS ONE 8(11): 10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116. https://doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116
Published: November 1, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.